2nd Quarter - Report

CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES

Firm
Client
Income
—
Expenses
$160,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Address provisions in patent reform legislation (HR 1260/S 515) to ensure maintenance of patent enforcement protections and strengthening of patent certainty and value.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1260 (111th)

Budget/Appropriations BUD

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpilefunding and preparation.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Education EDU

Support HR 5116, America COMPETES Act Reauthorization. Support education provisions of Labor/HHS/Ed appropriations.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5116 (111th)

Medical/Disease Research/Clinical Labs MED

Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education and strategic stockpilefunding and preparation.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Science/Technology SCI

Support HR 5116, America COMPETES Act Reauthorization.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5116 (111th)

Health Issues HCR

Address implementation of comparative effectiveness research provision of healthcare reform law. Address implementation/impact of Therapeutic Discovery Tax Credit provision of healthcare reform law. Address concerns with increasing uncertainty and unpredictability of FDA regulatory environment, incl 510(k) process.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Financial Institutions/Investments/Securities FIN

Support permanent exemption from Section 404(b) reporting requirements of the Sarbanes-Oxley Act for smaller issuers in financial services reform bill.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Address implementation/impact of Therapeutic Discovery Tax Credit provision of healthcare reform law.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Address implementation of comparative effectiveness research provision of healthcare reform law.

LobbyistCovered position, as disclosed
TODD E GILLENWATER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.